These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 10815288)

  • 1. [Cognitive and emotional disorders in multiple sclerosis. Can a management strategy be envisioned?].
    Pelletier J; Benoit N; Montreuil M; Habib M
    Pathol Biol (Paris); 2000 Mar; 48(2):121-31. PubMed ID: 10815288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cognitive impairment].
    Reuter F; Audoin B; Rico A; Malikova I; Ranjeva JP; Pelletier J
    Rev Neurol (Paris); 2009 Mar; 165 Suppl 4():S113-22. PubMed ID: 19361675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlating brain atrophy with cognitive dysfunction, mood disturbances, and personality disorder in multiple sclerosis.
    Benedict RH; Carone DA; Bakshi R
    J Neuroimaging; 2004 Jul; 14(3 Suppl):36S-45S. PubMed ID: 15228758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive changes in multiple sclerosis.
    Amato MP; Zipoli V; Portaccio E
    Expert Rev Neurother; 2008 Oct; 8(10):1585-96. PubMed ID: 18928350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Intellect and mood disorders in multiple sclerosis].
    Montreuil M; Derouesné C
    Rev Prat; 1991 Sep; 41(20):1913-8. PubMed ID: 1925376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective decline in information processing in subgroups of multiple sclerosis: an 8-year longitudinal study.
    Bergendal G; Fredrikson S; Almkvist O
    Eur Neurol; 2007; 57(4):193-202. PubMed ID: 17272938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive impairment in multiple sclerosis: evidence-based analysis and recommendations.
    Rogers JM; Panegyres PK
    J Clin Neurosci; 2007 Oct; 14(10):919-27. PubMed ID: 17659875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment and rehabilitation of cognitive impairment in multiple sclerosis.
    Messinis L; Kosmidis MH; Lyros E; Papathanasopoulos P
    Int Rev Psychiatry; 2010; 22(1):22-34. PubMed ID: 20233112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticholinesterasics in the treatment of cognitive impairment in multiple sclerosis.
    Porcel J; Montalban X
    J Neurol Sci; 2006 Jun; 245(1-2):177-81. PubMed ID: 16674980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing-remitting multiple sclerosis: baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study.
    Patti F; Amato MP; Trojano M; Bastianello S; Tola MR; Goretti B; Caniatti L; Di Monte E; Ferrazza P; Brescia Morra V; Lo Fermo S; Picconi O; Luccichenti G;
    Mult Scler; 2009 Jul; 15(7):779-88. PubMed ID: 19542262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Neuropsychological evaluation and psychopathology of multiple sclerosis].
    Defer G
    Rev Neurol (Paris); 2001 Sep; 157(8-9 Pt 2):1128-34. PubMed ID: 11787345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Neuropsychiatric and cognitive aspectos of multiple sclerosis].
    Carrá A; Drake M
    Vertex; 2002; 13(49):217-25. PubMed ID: 12404024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Neuropsychological evaluation in a case of multiple sclerosis].
    Sanz de la Torre JC; Pérez-Ríos M
    Rev Neurol; 2000 Jun 16-30; 30(12):1161-5. PubMed ID: 10935244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Psychological and neuropsychological problems in multiple sclerosis].
    Béquet D; Taillia H; Clervoy P; Renard JL; Flocard F
    Bull Acad Natl Med; 2003; 187(4):683-94; discussion 695-7. PubMed ID: 14556476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive impairment in multiple sclerosis.
    Patti F
    Mult Scler; 2009 Jan; 15(1):2-8. PubMed ID: 18805842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive functioning in children and adolescents with multiple sclerosis.
    MacAllister WS; Belman AL; Milazzo M; Weisbrot DM; Christodoulou C; Scherl WF; Preston TE; Cianciulli C; Krupp LB
    Neurology; 2005 Apr; 64(8):1422-5. PubMed ID: 15851734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive impairment and structural brain damage in benign multiple sclerosis.
    Rovaris M; Riccitelli G; Judica E; Possa F; Caputo D; Ghezzi A; Bertolotto A; Capra R; Falautano M; Mattioli F; Martinelli V; Comi G; Filippi M
    Neurology; 2008 Nov; 71(19):1521-6. PubMed ID: 18815387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Frontal dementia or dementia praecox? A case report of a psychotic disorder with a severe decline].
    Vanderzeypen F; Bier JC; Genevrois C; Mendlewicz J; Lotstra F
    Encephale; 2003; 29(2):172-80. PubMed ID: 14567169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of comorbid substance use on neuropsychological performance in subjects with psychotic or mood disorders].
    Liraud F; Verdoux H
    Encephale; 2002; 28(2):160-8. PubMed ID: 11972143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Neuropsychology of primary progressive multiple sclerosis].
    Paes RA; Alvarenga RM; Vasconcelos CC; Negreiros MA; Landeira-Fernández J
    Rev Neurol; 2009 Oct 1-15; 49(7):343-8. PubMed ID: 19774527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.